Successful treatment of acute Epstein-Barr virus infection associated with X-linked lymphoproliferative disorder with rituximab.
about
Characterization of Epstein-Barr virus (EBV)-infected cells in EBV-associated hemophagocytic lymphohistiocytosis in two patients with X-linked lymphoproliferative syndrome type 1 and type 2.2B4-SAP signaling is required for the priming of naive CD8+ T cells by antigen-expressing B cells and B lymphoma cells.Hemophagocytic lymphohistiocytosis: Pathogenesis, diagnosis, and management.EBV Infection in XLP1 Manifested Solely by Behavioral Aggression and Effective Treatment Using Rituximab.
P2860
Successful treatment of acute Epstein-Barr virus infection associated with X-linked lymphoproliferative disorder with rituximab.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Successful treatment of acute ...... ative disorder with rituximab.
@en
Successful treatment of acute ...... ative disorder with rituximab.
@nl
type
label
Successful treatment of acute ...... ative disorder with rituximab.
@en
Successful treatment of acute ...... ative disorder with rituximab.
@nl
prefLabel
Successful treatment of acute ...... ative disorder with rituximab.
@en
Successful treatment of acute ...... ative disorder with rituximab.
@nl
P2093
P356
P1476
Successful treatment of acute ...... rative disorder with rituximab
@en
P2093
Corrina Mc Mahon
Melanie Cotter
Owen Smith
Raveen Shahdadpuri
P304
P356
10.1002/PBC.21081
P577
2007-10-01T00:00:00Z